A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Advanced Malignant Neoplasm · Breast Cancer · Ovarian Cancer · Homologous Recombination Deficiency · Prostate Cancer · Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles, California, United States
Johns Hopkins, Baltimore, Maryland, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study leads
Pamela Munster, MD
Study Director
AtlasMedx, Incorporated